About
Maykin Ho, Ph.D. is a life-sciences finance executive and board director with more than 30 years in healthcare and biotechnology. She is a Venture Partner at Aulis Capital, previously served as a Venture Partner at Qiming Venture Partners from July 2015 to July 2025, and earlier was a longtime Goldman Sachs partner and senior biotechnology analyst. She currently sits on multiple public and private biopharma and research-related boards, including BioMarin, Agios, Kyntra Bio, Neumora, Parexel, the Aaron Diamond AIDS Research Center, and the Institute for Protein Innovation.
Areas of interest
biotechbiopharmahealthcare investingrare diseaseclinical researchprotein scienceregenerative medicinecapital markets